Understanding the Conformational Impact of Chemical
Modifications on Monoclonal Antibodies with Diverse Sequence Variation
Using Hydrogen/Deuterium Exchange Mass Spectrometry and Structural
Modeling
posted on 2014-04-01, 00:00authored byAming Zhang, Ping Hu, Paul MacGregor, Yu Xue, Haihong Fan, Peter Suchecki, Leonard Olszewski, Aston Liu
Chemical modifications can potentially
induce conformational changes
near the modification site and thereby impact the safety and efficacy
of protein therapeutics. Hydrogen/deuterium exchange mass spectrometry
(HDX-MS) has emerged as a powerful analytical technique with high
spatial resolution and sensitivity in detecting such local conformational
changes. In this study, we utilized HDX-MS combined with structural
modeling to examine the conformational impact on monoclonal antibodies
(mAbs) caused by common chemical modifications including methionine
(Met) oxidation, aspartic acid (Asp) isomerization, and asparagine
(Asn) deamidation. Four mAbs with diverse sequences and glycosylation
states were selected. The data suggested that the impact of Met oxidation
was highly dependent on its location and glycosylation state. For
mAbs with normal glycosylation in the Fc region, oxidation of the
two conserved Met252 and Met428 (Kabat numbering) disrupted the interface
interactions between the CH2 and CH3 domains, thus leading to a significant
decrease in CH2 domain thermal stability as well as a slight increase
in aggregation propensity. In contrast, Met oxidation in the variable
region and CH3 domain had no detectable impact on mAb conformation.
For aglycosylated mAb, Met oxidation could cause a more global conformational
change to the whole CH2 domain, coincident with the larger decrease
in thermal stability and significant increase in aggregation rate.
Unlike Met oxidation, Asn deamidation and Asp isomerization mostly
had very limited effects on mAb conformation, with the exception of
succiminide intermediate formation which induced a measurable local
conformational change to be more solvent protected. Structural modeling
suggested that the succinimide intermediate was stabilized by adjacent
aromatic amino acids through ring–ring stacking interactions.